融合成像引导热消融治疗常规或超声造影不可见肝细胞癌:周围解剖标志至关重要
研究分析37个B模式/超声造影不可见的肝细胞癌结节,在清醒镇静下仅用融合成像(基于既往CT或MR)引导热消融。初次有效率为59.4%,二次有效率为81.1%,局部肿瘤进展率6.7%;周围解剖标志与更好的消融结局相关(37.5% vs 84.6%,p=0.01)。作者认为即使存在完全不可见结节、自主呼吸和既往影像等潜在困难条件,仅融合成像引导仍安全且可获得较好的初次、二次有效率和局部肿瘤进展率,结局受周围解剖标志显著影响。
要点
- B模式/超声造影不可见肝细胞癌结节仅用融合成像引导消融,初次有效率59.4%。
- 有周围解剖标志者消融成功率84.6%,无标志者仅37.5%(p=0.01)。
- 未完全消融者二次消融后二次有效率81.1%,局部肿瘤进展率6.7%。
核心结论
- 即使结节完全不可见、患者自主呼吸且使用既往CT或MRI,仅融合成像引导消融仍安全,初次、二次有效率和局部肿瘤进展率均较好。
- 消融结局受周围解剖标志存在的显著影响(37.5% vs 84.6%,p=0.01)。
研究设计与样本
- 回顾性提取前瞻性收集的机构数据库数据,研究期间共治疗367个肝细胞癌结节,其中37个B模式/超声造影不可见结节接受融合成像引导消融。
- 融合成像基于既往获得的CT或MR,操作在清醒镇静下进行。
- 分析变量包括患者性别、年龄、肝硬化病因、Child-Pugh状态、病灶大小、肝段、包膜下或中央位置、融合所用影像类型(MR/CT)以及距指标病灶<3 cm的周围解剖标志存在与否。
诊断标准与关键数值
- 初次有效率59.4%(22/37个结节)。
- 部分消融9个病灶(24.3%),误靶消融6个病灶(16.7%)。
- 8个结节再次消融后全部获得完全消融(100%完全消融),二次有效率为81.1%(30/37)。
- 局部肿瘤进展见于2/30例(6.7%)。
- 轻微并发症2例(Clavien-Dindo 1级,CIRSE分类2级)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: Evaluating clinical and technical factors affecting thermal ablation of B-Mode/CEUS inconspicuous HCC nodules, relying only on fusion imaging (FI) performed under conscious sedation and using previously acquired CT or MR.
MATERIALS AND METHODS: Among 367 HCC nodules treated in the study period, data of 37 B-mode/CEUS undetectable HCC nodules treated with FI-guided ablation were extracted from our prospectively collected institutional database. Analyzed variables included patients' sex, age, cirrhosis etiology, Child-Pugh status, size of the lesion, liver segment, subcapsular or central liver site, type of imaging used for fusion (MR/CT), and the presence of surrounding anatomical landmarks (SAL) < 3 cm from the index lesion.
RESULTS: The primary efficacy was 59.4% (22/37 nodules); nine lesions (24.3%) were partially ablated (PA), six lesions (16.7%) were mistargeted (MA). Eight nodules were retreated with a CA obtained in all cases (100% CA, secondary efficacy in 30/37-81.1%). LTP was observed in 2/30 cases (6.7%). Two minor complications were registered (Clavien-Dindo, Grade1, CIRSE Classification Grade 2). SAL were related to a better ablation outcome (37.5% vs 84.6% p = 0.01). No differences were observed between CA group and PA-MA group in terms of lesion size (15.4 mm vs 14.9 mm p = 0.63), liver segment (p = 0.58), subcapsular or central liver site (8/22 36% vs 4/15 26.7% p = 0.84), and imaging (MR vs CT, p = 0.72).
CONCLUSION: Even in the presence of potentially critical conditions (completely B-Mode/CEUS inconspicuous nodules, spontaneous breathing, and previously acquired CT or MRI), FI-only guidance is safe and allows having good primary, secondary efficacy and LTP rates. The outcome of the procedure is heavily affected by the presence of SAL.
引用
- Calandri M, Ruggeri V, Carucci P, et al. Thermal ablation with fusion imaging guidance of hepatocellular carcinoma without conspicuity on conventional or contrast-enhanced US: surrounding anatomical landmarks matter. Radiol Med. 2019. PMID: 31270723. doi:10.1007/s11547-019-01057-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。